Multiple sclerosis as a vascular disease

Neurological Research

Volumn 28, Issue 3, 2006, Pages 230-235

  Minagar, Alireza ^a   Jy, Wenche ^c   Jimenez, J J ^c   Alexander, J Steven ^b,d  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Blood brain barrier; Cerebral endothelial cells; Multiple sclerosis; Transendothelial migration

Indexed keywords

CD4 ANTIGEN; MATRIX METALLOPROTEINASE; PROTEIN ZO1;

BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; REVIEW; VASCULAR DISEASE;

ANTIBODY SPECIFICITY; B-LYMPHOCYTES; BLOOD-BRAIN BARRIER; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS;

EID: 33646818945     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X98080     Document Type: Review

References (28)

1. Grieb P, Forster RE, Strome D, et al. O2 exchange between blood and brain tissues studied with 18O2 indicator-dilution technique. J Appl Physiol 1985; 58: 1929-1941
2. Hirase T, Staddon JM, Saitou M, et al. Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 1997; 110: 1603-1613
3. Lassmann H, Raine CS, Antel J, et al. Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 1998; 86: 213-217
4. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285
5. Engelhardt B, Kempe B, Merfeld-Clauss S, et al. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice. J Immunol 2005; 175: 1267-1275
6. Sheremata WA, Minagar A, Alexander JS, et al. The role of alpha-4 integrin in the aetiology of multiple sclerosis: Current knowledge and therapeutic implications. CNS Drugs 2005; 19: 909-922
7. Losy J, Niezgoda A, Wender M. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J Neuroimmunol 1999; 99: 169-172
8. Minagar A, Jy W, Jimenez JJ, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001; 56: 1319-1324
9. Minagar A, Ostanin D, Long AC, et al. Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells. Mult Scler 2003; 9: 235-238
10. Minagar A, Long A, Ma T, et al. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 2003; 10: 299-307
11. Kirk J, Plumb J, Mirakhur M, et al. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 2003; 201: 319-327
12. van Horssen J, Bo L, Vos CM, et al. Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: Potential role in influx and transport of leukocytes. J Neuropathol Exp Neurol 2005; 64: 722-729
13. van der Maesen K, Hinojoza JR, Sobel RA. Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions. J Neuropathol Exp Neurol 1999; 58: 346-358
14. Wiendl H, Feger U, Mittelbronn M, et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: Implications for CNS immunity. Brain 2005; 128: 2689-2704
15. Franzen B, Duvefelt K, Jonsson C, et al. Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-alpha. Brain Res Mol Brain Res 2003; 115: 130-146
16. Rosenberg GA. Matrix metalloproteinases and neuroinflammation in multiple sclerosis. Neuroscientist 2002; 8: 586-595
17. Yong VW. Differential mechanisms of action of interferon-beta and glatiramer acetate in MS. Neurology 2002; 59: 802-808
18. Arkell J, Jackson CJ. Constitutive secretion of MMP9 by early-passage cultured human endothelial cells. Cell Biochem Funct 2003; 21: 381-386
19. Kouwenhoven M, Ozenci V, Tjernlund A, et al. Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis. J Neuroimmunol 2002; 126: 161-171
20. Leppert D, Ford J, Stabler G, et al. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 1998; 121: 2327-2334
21. Lee MA, Palace J, Stabler G, et al. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain 1999; 122: 191-197
22. Avolio C, Filippi M, Tortorella C, et al. Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: Relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult Scler 2005; 11: 441-446
23. Jy W, Minagar A, Jimenez JJ, et al. Endothelial microparticles (EMP) bind and activate monocytes: Elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci 2004; 9: 3137-3144
24. Li DK, Paty DW. Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis. Ann Neurol 1999; 46: 197-206
25. Kraus J, Ling AK, Hamm S, et al. Interferon-β stabilizes barrier characteristics of brain endothelial cells in vitro. Ann Neurol 2004; 56: 192-205
26. Harzheim M, Stepien-Mering M, Schroder R, et al. The expression of microfilament-associated cell-cell contacts in brain endothelial cells is modified by IFN-beta1a (Rebif). J Interferon Cytokine Res 2004; 24: 711-716
27. Jimenez JJ, Jy W, Mauro LM, et al. Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes. Mult Scler 2005; 11: 310-315
28. Rao RK, Basuroy S, Rao VU, et al. Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 2002; 368: 471-481